SLSN — Solesence Share Price
0.000.00%
Last trade - 00:00- $174.56m
- $178.15m
- $52.35m
- 55
- 27
- 64
- 47
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 11.68 | ||
| Price to Tang. Book | 11.68 | ||
| Price to Free Cashflow | n/a | ||
| Price to Sales | 3.33 | ||
| EV to EBITDA | 29.4 | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | 21.18% | ||
| Return on Equity | 50.27% | ||
| Operating Margin | 9.8% | ||
Financial Summary
| Year End 31st Dec | Unit | 2020 | 2021 | 2022 | 2023 | 2024 | 2025E | 2026E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | $m | 17.12 | 29.48 | 37.32 | 37.3 | 52.35 | n/a | n/a | 33.15% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | +14.58 | n/a | n/a | n/a | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Solesence, Inc., formerly Nanophase Technologies Corporation, provides healthcare solutions across beauty and life science categories. It is a developer and manufacturer of clean, inclusive, mineral-based skincare and makeup products. The Company partners with global and indie brands, leveraging its proprietary Active Stress Defense technology suite (Original Active Stress Defense, Kleair, and Bloom) to bring environmental protection beauty products to market via over a dozen market-ready offerings that embrace self-expression, health care, and self-care across skin care and color cosmetic categories. It also offers custom development, with turnkey options available across all paths to market. The Company’s products are formulated using its own mineral sunscreen actives, which are produced in its Chicagoland facility where it has been producing sunscreen actives, including the zinc oxide sunscreen active.
Directors
- Rebecca Whitmore CHM (66)
- Jess Jankowski PRE (55)
- Kevin Cureton COO (58)
- Laura Beres IND (37)
- Richard Siegel IND (83)
- George Vincent IND (76)
- Last Annual
- December 31st, 2024
- Last Interim
- December 31st, 2024
- Incorporated
- November 12th, 1997
- Public Since
- November 28th, 1997
- No. of Shareholders
- 120
- No. of Employees
- 98
- Sector
- Personal & Household Products & Services
- Industry
- Consumer Defensives
- Exchange
- NASDAQ Capital Market
- Shares in Issue
- 70,103,279
- Address
- 1319 MARQUETTE DRIVE, ROMEOVILLE, 60446
- Web
- https://ir.solesence.com/
- Phone
- +1 6307716078
- Auditors
- RSM US LLP
Upcoming Events for SLSN
Similar to SLSN
Beauty Health Co
NASDAQ Capital Market
Caring Brands
NASDAQ Capital Market
China Liberal Education Holdings
NASDAQ Capital Market
Color Star Technology Co
NASDAQ Capital Market
E-Home Household Service Holdings
NASDAQ Capital Market
FAQ
What is the Solesence share price?
As of Today at 23:22 UTC, shares in Solesence are trading at $2.49. This share price information is delayed by 15 minutes.
How has the Solesence share price performed this year?
Shares in Solesence last closed at $2.49 and the price had moved by +116.52% over the past 365 days. In terms of relative price strength the Solesence share price has outperformed the S&P500 Index by +99.86% over the past year.
What are the analyst and broker recommendations for Solesence?
There is no consensus recommendation for this security.
Find out moreWhat is the Solesence dividend yield?
Solesence does not currently pay a dividend.
Does Solesence pay a dividend?
Solesence does not currently pay a dividend.
When does Solesence next pay dividends?
Solesence does not currently pay a dividend.
How do I buy Solesence shares?
To buy shares in Solesence you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
What is the market cap of Solesence?
As of the previous close price of $2.49, shares in Solesence had a market capitalisation of $174.56m.
Where are Solesence shares listed?
Here are the trading details for Solesence:
- Country of listing: United States
- Exchange: NAQ
- Ticker Symbol: SLSN
What kind of share is Solesence?
Based on an overall assessment of its quality, value and momentum Solesence is currently classified as a Neutral. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
Is there a Solesence share price forecast for 2025?
We could not find analyst target price data for this security.
Find out moreWhat is the trend in the Solesence share price?
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Solesence. Over the past six months, its share price has outperformed the S&P500 Index by +70.42%.
As of the last closing price of $2.49, shares in Solesence were trading +18.17% higher than their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
What is the Solesence PE Ratio?
The Solesence PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at $2.49.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Who are the key directors of Solesence?
Solesence's management team is headed by:
- Rebecca Whitmore - CHM
- Jess Jankowski - PRE
- Kevin Cureton - COO
- Laura Beres - IND
- Richard Siegel - IND
- George Vincent - IND